-
FDA declines to approve Takeda diabetes drug
DEERFIELD, Ill. — The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.
Takeda announced that the FDA issued a complete response letter for its regulatory applications for the Type 2 diabetes drug alogliptin and a combination pill that includes alogliptin and pioglitazone, the active ingredient in the drug Actos.
-
Walgreens outlines results of medication adherence studies
DEERFIELD, Ill. — Walgreens unveiled the results of research, conducted by the drug store chain, that demonstrated how its approach to community pharmacy ultimately helped improve outcomes through cost savings, pharmacist-led face-to-face patient counseling and specialized services for disease management.
New research results, presented by Walgreens at the Academy of Managed Care Pharmacy's 24th Annual Meeting and Expo last week in San Francisco, included: